Skip to main content

IV Secukinumab for AxSpa The FDA recently announced approval for intravenous secukinumab (Cosentyx) for adults with ps

Nov 20, 2023 9:04 am
Social Author Name
Dr. John Cush
Tweet Content
IV Secukinumab for AxSpa The FDA recently announced approval for intravenous secukinumab (Cosentyx) for adults with psoriatic arthritis, ankylosing spondylitis, and non-radiographic spondylitis. https://t.co/JhOvPIXOMN https://t.co/GoV62NjSmf
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×